This is a positive signal — lower values indicate better performance for this metric.
An increase relative to premiums may signal rising drug costs or higher utilization, potentially compressing margins, while a decrease relative to premiums suggests improved cost management.
The total costs incurred by the CarelonRx segment related to the provision of pharmacy benefits to covered members. This...
Comparable to medical or pharmacy benefit claims expenses reported by other health insurers.
elv_segment_carelonrx_benefit_expense| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |